{"success":true,"data":{"pressRelease":{"id":"145145","rtpr_id":"nBw3x8qTPa-20260916","ticker":"MTO","exchange":"LSE","all_tickers":["MTO"],"title":"REG-Qube Research & Technologies LTD Form 8.3","author":"Business Wire","published_at":"2026-09-16T12:05:00.146Z","article_body":"Form 8.3\n\n \n\nFORM 8.3\n\nPUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY\n\nA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE\n\nRule 8.3 of the Takeover Code (the “Code”)\n\n1. KEY INFORMATION\n (a) Full name of discloser: Qube Research & Technologies Limited \n (b) Owner or controller of interests and short positions disclosed, if   \n different from 1(a): \n \n \n \nThe naming of nominee or vehicle companies is insufficient. For a trust, the \n trustee(s), settlor and beneficiaries must be named. \n (c) Name of offeror/offeree in relation to whose relevant securities this form Mitie Group plc \n relates: \n \n \n \nUse a separate form for each offeror/offeree \n (d) If an exempt fund manager connected with an offeror/offeree, state this   \n and specify identity of offeror/offeree: \n (e) Date position held/dealing undertaken: 15-09-2026 \n \n \n \nFor an opening position disclosure, state the latest practicable date prior to \n the disclosure \n (f) In addition to the company in 1(c) above, is the discloser making N/A \n disclosures in respect of any other party to the offer? \n \n \n \n  \n \nIf it is a cash offer or possible cash offer, state “N/A” \n\n\n2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE\n\nIf there are positions or rights to subscribe to disclose in more than one\nclass of relevant securities of the offeror or offeree named in 1(c), copy\ntable 2(a) or (b) (as appropriate) for each additional class of relevant\nsecurity.\n\n(a) Interests and short positions in the relevant securities of the offeror or\nofferee to which the disclosure relates following the dealing (if any)\n Class of relevant security: 2.5p ordinary \n \n \n \n  \n   Interests Short positions \n \n \n \n  \n Number % Number % \n (1) Relevant securities owned and/or controlled: 0 0.00 0 0.00 \n (2) Cash-settled derivatives: 28,988,634 2.22 0 0.00 \n (3) Stock-settled derivatives (including options) and agreements to 0 0.00 0 0.00 \n purchase/sell: \n TOTAL: 28,988,634 2.22 0 0.00 \n\n\nAll interests and all short positions should be disclosed.\n\nDetails of any open stock-settled derivative positions (including traded\noptions), or agreements to purchase or sell relevant securities, should be\ngiven on a Supplemental Form 8 (Open Positions).\n\n(b) Rights to subscribe for new securities (including directors’ and other\nemployee options)\n Class of relevant security in relation to which subscription right exists: 0 \n Details, including nature of the rights concerned and relevant percentages: 0 \n\n\n3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE\n\nWhere there have been dealings in more than one class of relevant securities\nof the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as\nappropriate) for each additional class of relevant security dealt in.\n\nThe currency of all prices and other monetary amounts should be stated.\n\n(a) Purchases and sales\n Class of relevant security Purchase/sale Number of securities Price per unit (CCY0) \n \n \n \n  \n\n\n(b) Cash-settled derivative transactions\n Class of relevant security Product description Nature of dealing Number of securities Exercise price per unit (GBp) \n \n \n \n \ne.g. call option \ne.g. opening/closing a long/short position, increasing/reducing a long/short \n position \n 2.5p ordinary equity swap decreasing a long position 6259 209.40 \n 2.5p ordinary equity swap decreasing a long position 2561 209.50 \n 2.5p ordinary equity swap decreasing a long position 58346 209.60 \n 2.5p ordinary equity swap decreasing a long position 1784 209.70 \n 2.5p ordinary equity swap decreasing a long position 65977 210.00 \n 2.5p ordinary equity swap decreasing a short position 120 209.00 \n 2.5p ordinary equity swap decreasing a short position 1191 210.00 \n 2.5p ordinary equity swap decreasing a short position 102 210.40 \n 2.5p ordinary equity swap increasing a long position 193 209.00 \n 2.5p ordinary equity swap increasing a long position 727 209.50 \n 2.5p ordinary equity swap increasing a long position 45966 209.60 \n 2.5p ordinary equity swap increasing a long position 1786 209.70 \n 2.5p ordinary equity swap increasing a long position 4569 209.80 \n 2.5p ordinary equity swap increasing a long position 1884 210.00 \n 2.5p ordinary equity swap increasing a long position 417 210.40 \n\n\n(c) Stock-settled derivative transactions (including options)\n\n(i) Writing, selling, purchasing or varying\n Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit (CCY0) Type Expiry date Option money paid/ received per unit \n \n \n \n \ne.g. American, European etc. \n(CCY0) \n\n\n(ii) Exercise\n Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit \n \n \n \ne.g. call option \n 0 0 0 0   \n \n \n \n0 \n\n\n(d) Other dealings (including subscribing for new securities)\n Class of relevant security Nature of dealing Details Price per unit (if applicable) \n \n \n \ne.g. subscription, conversion \n 0   0 0 \n \n \n \n0 \n\n\n4. OTHER INFORMATION\n\n(a) Indemnity and other dealing arrangements\n Details of any indemnity or option arrangement, or any agreement or \n understanding, formal or informal, relating to relevant securities which may \n be an inducement to deal or refrain from dealing entered into by the person \n making the disclosure and any party to the offer or any person acting in \n concert with a party to the offer: \n \n \n \nIrrevocable commitments and letters of intent should not be included. If there \n are no such agreements, arrangements or understandings, state “none” \n   \n \n \n \nNone \n \n \n \n  \n\n\n(b) Agreements, arrangements or understandings relating to options or\nderivatives\n Details of any agreement, arrangement or understanding, formal or informal, \n between the person making the disclosure and any other person relating to: \n \n \n \n(i) the voting rights of any relevant securities under any option; or \n \n \n \n(ii) the voting rights or future acquisition or disposal of any relevant \n securities to which any derivative is referenced: \n \n \n \nIf there are no such agreements, arrangements or understandings, state \n “none” \n   \n \n \n \nNone \n \n \n \n  \n\n\n(c) Attachments\n Is a Supplemental Form 8 (Open Positions) attached? NO \n\n Date of disclosure: 16-09-2026 \n Contact name: Janice Falcao \n Telephone number: 00442033140679 \n\n\nPublic disclosures under Rule 8 of the Code must be made to a Regulatory\nInformation Service.\n\nThe Panel’s Market Surveillance Unit is available for consultation in\nrelation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The\nCode can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk%2F&esheet=54605416&newsitemid=20260916226253&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=1&md5=53feaa15025daa09b0b0502a7ef06fdd)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260916226253/en/\n(https://www.businesswire.com/news/home/20260916226253/en/)\n\nQube Research & Technologies LTD\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw3x8qTPa-20260916","title":"REG-Qube Research & Technologies LTD Form 8.3","author":"Business Wire","ticker":"MTO","created":"2026-09-16T12:05:00.146Z","tickers":["MTO"],"exchange":"LSE","article_body":"Form 8.3\n\n \n\nFORM 8.3\n\nPUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY\n\nA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE\n\nRule 8.3 of the Takeover Code (the “Code”)\n\n1. KEY INFORMATION\n (a) Full name of discloser: Qube Research & Technologies Limited \n (b) Owner or controller of interests and short positions disclosed, if   \n different from 1(a): \n \n \n \nThe naming of nominee or vehicle companies is insufficient. For a trust, the \n trustee(s), settlor and beneficiaries must be named. \n (c) Name of offeror/offeree in relation to whose relevant securities this form Mitie Group plc \n relates: \n \n \n \nUse a separate form for each offeror/offeree \n (d) If an exempt fund manager connected with an offeror/offeree, state this   \n and specify identity of offeror/offeree: \n (e) Date position held/dealing undertaken: 15-09-2026 \n \n \n \nFor an opening position disclosure, state the latest practicable date prior to \n the disclosure \n (f) In addition to the company in 1(c) above, is the discloser making N/A \n disclosures in respect of any other party to the offer? \n \n \n \n  \n \nIf it is a cash offer or possible cash offer, state “N/A” \n\n\n2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE\n\nIf there are positions or rights to subscribe to disclose in more than one\nclass of relevant securities of the offeror or offeree named in 1(c), copy\ntable 2(a) or (b) (as appropriate) for each additional class of relevant\nsecurity.\n\n(a) Interests and short positions in the relevant securities of the offeror or\nofferee to which the disclosure relates following the dealing (if any)\n Class of relevant security: 2.5p ordinary \n \n \n \n  \n   Interests Short positions \n \n \n \n  \n Number % Number % \n (1) Relevant securities owned and/or controlled: 0 0.00 0 0.00 \n (2) Cash-settled derivatives: 28,988,634 2.22 0 0.00 \n (3) Stock-settled derivatives (including options) and agreements to 0 0.00 0 0.00 \n purchase/sell: \n TOTAL: 28,988,634 2.22 0 0.00 \n\n\nAll interests and all short positions should be disclosed.\n\nDetails of any open stock-settled derivative positions (including traded\noptions), or agreements to purchase or sell relevant securities, should be\ngiven on a Supplemental Form 8 (Open Positions).\n\n(b) Rights to subscribe for new securities (including directors’ and other\nemployee options)\n Class of relevant security in relation to which subscription right exists: 0 \n Details, including nature of the rights concerned and relevant percentages: 0 \n\n\n3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE\n\nWhere there have been dealings in more than one class of relevant securities\nof the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as\nappropriate) for each additional class of relevant security dealt in.\n\nThe currency of all prices and other monetary amounts should be stated.\n\n(a) Purchases and sales\n Class of relevant security Purchase/sale Number of securities Price per unit (CCY0) \n \n \n \n  \n\n\n(b) Cash-settled derivative transactions\n Class of relevant security Product description Nature of dealing Number of securities Exercise price per unit (GBp) \n \n \n \n \ne.g. call option \ne.g. opening/closing a long/short position, increasing/reducing a long/short \n position \n 2.5p ordinary equity swap decreasing a long position 6259 209.40 \n 2.5p ordinary equity swap decreasing a long position 2561 209.50 \n 2.5p ordinary equity swap decreasing a long position 58346 209.60 \n 2.5p ordinary equity swap decreasing a long position 1784 209.70 \n 2.5p ordinary equity swap decreasing a long position 65977 210.00 \n 2.5p ordinary equity swap decreasing a short position 120 209.00 \n 2.5p ordinary equity swap decreasing a short position 1191 210.00 \n 2.5p ordinary equity swap decreasing a short position 102 210.40 \n 2.5p ordinary equity swap increasing a long position 193 209.00 \n 2.5p ordinary equity swap increasing a long position 727 209.50 \n 2.5p ordinary equity swap increasing a long position 45966 209.60 \n 2.5p ordinary equity swap increasing a long position 1786 209.70 \n 2.5p ordinary equity swap increasing a long position 4569 209.80 \n 2.5p ordinary equity swap increasing a long position 1884 210.00 \n 2.5p ordinary equity swap increasing a long position 417 210.40 \n\n\n(c) Stock-settled derivative transactions (including options)\n\n(i) Writing, selling, purchasing or varying\n Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit (CCY0) Type Expiry date Option money paid/ received per unit \n \n \n \n \ne.g. American, European etc. \n(CCY0) \n\n\n(ii) Exercise\n Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit \n \n \n \ne.g. call option \n 0 0 0 0   \n \n \n \n0 \n\n\n(d) Other dealings (including subscribing for new securities)\n Class of relevant security Nature of dealing Details Price per unit (if applicable) \n \n \n \ne.g. subscription, conversion \n 0   0 0 \n \n \n \n0 \n\n\n4. OTHER INFORMATION\n\n(a) Indemnity and other dealing arrangements\n Details of any indemnity or option arrangement, or any agreement or \n understanding, formal or informal, relating to relevant securities which may \n be an inducement to deal or refrain from dealing entered into by the person \n making the disclosure and any party to the offer or any person acting in \n concert with a party to the offer: \n \n \n \nIrrevocable commitments and letters of intent should not be included. If there \n are no such agreements, arrangements or understandings, state “none” \n   \n \n \n \nNone \n \n \n \n  \n\n\n(b) Agreements, arrangements or understandings relating to options or\nderivatives\n Details of any agreement, arrangement or understanding, formal or informal, \n between the person making the disclosure and any other person relating to: \n \n \n \n(i) the voting rights of any relevant securities under any option; or \n \n \n \n(ii) the voting rights or future acquisition or disposal of any relevant \n securities to which any derivative is referenced: \n \n \n \nIf there are no such agreements, arrangements or understandings, state \n “none” \n   \n \n \n \nNone \n \n \n \n  \n\n\n(c) Attachments\n Is a Supplemental Form 8 (Open Positions) attached? NO \n\n Date of disclosure: 16-09-2026 \n Contact name: Janice Falcao \n Telephone number: 00442033140679 \n\n\nPublic disclosures under Rule 8 of the Code must be made to a Regulatory\nInformation Service.\n\nThe Panel’s Market Surveillance Unit is available for consultation in\nrelation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The\nCode can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk%2F&esheet=54605416&newsitemid=20260916226253&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=1&md5=53feaa15025daa09b0b0502a7ef06fdd)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260916226253/en/\n(https://www.businesswire.com/news/home/20260916226253/en/)\n\nQube Research & Technologies LTD\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-09-16T12:05:00.197038043Z","server_sent_at_ms":1789560300197},"received_at":"2026-09-16T12:05:00.255Z","source_url":"https://www.businesswire.com/news/home/20260916226253/en/"},"analysis":{"id":"133978","press_release_id":"145145","analysis_json":{"industry":{"label":"Environmental & Facilities Services","sector":"Industrials"},"redFlags":["Rule 8.3 filing implies Mitie Group plc is in a UK Takeover Code offer period, so MTO shareholders face deal-outcome uncertainty","Day's dealing skewed toward reducing long swap exposure despite retaining the 2.22% position"],"eventType":"regulatory","narrative":"Qube Research & Technologies Limited filed a Rule 8.3 Takeover Code disclosure showing it held 28,988,634 cash-settled derivative interests in Mitie Group plc, equal to 2.22% of the 2.5p ordinary shares, with no short positions, as of September 15, 2026.\n\nOn the dealing day Qube both trimmed and added long equity swap exposure, including a 65,977-security long reduction at 210.00 GBp and a 45,966-security long increase at 209.60 GBp, with trades priced between 209.00 and 210.40 GBp.\n\nThe form is a mandatory positional disclosure during a Takeover Code offer period and states there are no indemnity arrangements, irrevocable commitments, or agreements covering voting rights or derivative-referenced securities.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine Takeover Code filing — quant fund Qube trims long swap exposure but keeps a 2.22% derivative stake in Mitie during the offer period."},"keyFigures":{"customDimensions":{"position_date":"2026-09-15","short_positions":0,"cash_settled_derivatives_long":28988634,"percent_of_relevant_securities":"2.22%","largest_long_increase_securities":45966,"largest_long_reduction_securities":65977}},"namedEntities":{"people":[{"name":"Janice Falcao","role":"disclosure contact for Qube Research & Technologies"}],"products":["equity swap"],"companies":[{"name":"Qube Research & Technologies Limited","relationship":"disclosing 1%+ position holder (private quant fund)"},{"name":"Mitie Group plc","ticker":"MTO","relationship":"offeror/offeree company to which the disclosure relates"}],"dollarAmounts":[{"amount":"28,988,634","context":"cash-settled derivative interests in Mitie 2.5p ordinary shares held by Qube"},{"amount":"210.00","context":"GBp price of largest equity swap trade decreasing a long position (65,977 securities)"},{"amount":"209.60","context":"GBp price of largest equity swap trade increasing a long position (45,966 securities)"}]},"materialImpact":{"score":2,"reasoning":"Routine Rule 8.3 UK Takeover Code position/dealing disclosure by Qube Research & Technologies regarding Mitie Group plc. It adds no new deal terms or company guidance, but confirms a 2.22% cash-settled derivative long in the company during an offer period."},"tickerRelevance":{"others":[],"primary":"MTO"},"globalImportance":12,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"UK mid-cap (FTSE 250)","dealContext":"disclosure implies an active offer period for Mitie Group plc","eventGravity":"routine Rule 8.3 position/dealing disclosure","jurisdiction":"UK Takeover Code","issuerAuthored":false}},"event_type":"regulatory","event_type_secondary":null,"sentiment":"neutral","material_impact_score":2,"narrative":"Qube Research & Technologies Limited filed a Rule 8.3 Takeover Code disclosure showing it held 28,988,634 cash-settled derivative interests in Mitie Group plc, equal to 2.22% of the 2.5p ordinary shares, with no short positions, as of September 15, 2026.\n\nOn the dealing day Qube both trimmed and added long equity swap exposure, including a 65,977-security long reduction at 210.00 GBp and a 45,966-security long increase at 209.60 GBp, with trades priced between 209.00 and 210.40 GBp.\n\nThe form is a mandatory positional disclosure during a Takeover Code offer period and states there are no indemnity arrangements, irrevocable commitments, or agreements covering voting rights or derivative-referenced securities.","key_figures":{"customDimensions":{"position_date":"2026-09-15","short_positions":0,"cash_settled_derivatives_long":28988634,"percent_of_relevant_securities":"2.22%","largest_long_increase_securities":45966,"largest_long_reduction_securities":65977}},"named_entities":{"people":[{"name":"Janice Falcao","role":"disclosure contact for Qube Research & Technologies"}],"products":["equity swap"],"companies":[{"name":"Qube Research & Technologies Limited","relationship":"disclosing 1%+ position holder (private quant fund)"},{"name":"Mitie Group plc","ticker":"MTO","relationship":"offeror/offeree company to which the disclosure relates"}],"dollarAmounts":[{"amount":"28,988,634","context":"cash-settled derivative interests in Mitie 2.5p ordinary shares held by Qube"},{"amount":"210.00","context":"GBp price of largest equity swap trade decreasing a long position (65,977 securities)"},{"amount":"209.60","context":"GBp price of largest equity swap trade increasing a long position (45,966 securities)"}]},"model_name":"glm-5.3-flash","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-16T12:05:53.608Z","global_importance":12,"audience_relevance":10,"importance_components":{"tickerTier":"UK mid-cap (FTSE 250)","dealContext":"disclosure implies an active offer period for Mitie Group plc","eventGravity":"routine Rule 8.3 position/dealing disclosure","jurisdiction":"UK Takeover Code","issuerAuthored":false}},"durationMs":53336,"modelName":"glm-5.3-flash"}}